aTyr Pharma (LIFE) Misses Q2 EPS by 6c
aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.